Immucell (ICCC) EPS (Basic) Growth (3y) (2013 - 2026)
Powered by 
Analysis
Immucell (ICCC) EPS (Basic) Growth (3y) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.57 Bn | 40.38 Bn | 779.09 Mn | 16.67% |
| 2 | Zoetis | 30.57 Bn | 28.90 Bn | 1.05 Bn | 3.18% |
| 3 | Elanco Animal Health | 11.47 Bn | 10.94 Bn | 798.00 Mn | 36.60% |
| 4 | Phibro Animal Health | 1.43 Bn | 1.35 Bn | 134.40 Mn | 36.10% |
| 5 | Immucell | 87.38 Mn | 78.52 Mn | 2.44 Mn | 46.38% |
| 6 | Zhengye Biotechnology Holding | 64.40 Mn | 57.30 Mn | - | - |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - | -4.99% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 46.38% |
| Dec 31, 2025 | -25.50% |
| Sep 30, 2025 | 43.26% |
| Jun 30, 2025 | 34.80% |
| Mar 31, 2025 | 19.25% |
| Dec 31, 2024 | 110.07% |
| Sep 30, 2024 | -86.65% |
| Jun 30, 2024 | -132.96% |
| Mar 31, 2024 | 2.59% |
| Dec 31, 2023 | 57.00% |
| Sep 30, 2023 | -39.43% |
| Jun 30, 2023 | -18.82% |
| Mar 31, 2023 | -160.26% |
| Dec 31, 2022 | -47.78% |
| Sep 30, 2022 | -6.65% |
| Jun 30, 2022 | -12.45% |
| Mar 31, 2022 | 54.63% |
| Dec 31, 2021 | 27.39% |
| Sep 30, 2021 | 34.23% |
| Jun 30, 2021 | 28.59% |